EPT FUMARATE: A NOVEL AGENT FOR CANCER THERAPY?

EPT fumarate may be a recently identified compound that shows promising activity against a range of cancer types. This novel agent operates by affecting the cellular environment, likely leading to tumor growth inhibition. While preliminary studies have shown encouraging findings, further exploration is required to fully determine its potency and si

it might result in dizziness or fainting in certain people, particularly when they very first start off taking the medicine, change dose, or drink alcohol. Caution needs to be exercised in using Adalat Oros in aged people, especially These having a heritage of hypotension or cerebral vascular insufficiency. Lower doses may very well be essential i